Concepedia

C. H. Nash

CH

Statistics

Publications

25

Citations

786

H-Index

16

Active since

1968

Affiliations

Eli Lilly (United States)(Current)

Upsher-Smith Laboratories (United Kingdom)

Sterling Research Group (United States)

C. H. Nash is an author at Eli Lilly (United States) specializing in life sciences, microbiology, and biochemistry.

Publications per year

1968–1997

25

Publications

25

Ras oncoprotein inhibitors: The discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex

Arthur G. Taveras, Stacy Remiszewski, Ronald J. Doll et al. · Bioorganic & Medicinal Chemistry · 1997 · 123 citations

, , +17

Antibiotic Synthesis and Morphological Differentiation of <i>Cephalosporium acremonium</i>

C. H. Nash, F. M. Huber · Applied Microbiology · 1971 · 76 citations · Full text

, , +16

Antibiotic Synthesis and Morphological Differentiation of Cephalosporium acremonium

C. H. Nash, F. M. Huber · Applied Microbiology · 1971 · 56 citations · Full text

, , +7

Incorporation of (2RS,3S)-[4-13C]-valine into cephalosporin C

Norbert Neuss, C. H. Nash, Jack E. Baldwin et al. · Journal of the American Chemical Society · 1973 · 52 citations

, , +7

Biosynthesis of Mycophenolic Acid: Purification and Characterization of <i>S</i> -Adenosyl- <scp>l</scp> -Methionine:Demethylmycophenolic Acid <i>O</i> -Methyltransferase

William L. Muth, C. H. Nash · Antimicrobial Agents and Chemotherapy · 1975 · 48 citations · Full text

, , +17

1–5 of 25